Sekikaic Acid | CAS#607-11-4 | Diverse lichen metabolite

MedKoo Cat#: 464990 | Name: Sekikaic Acid

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sekikaic acid is a phenolic lichen metabolite that has been found in H. obscurata and has diverse biological activities. It scavenges superoxide and DPPH radicals in cell-free assays when used at a concentration of 0.5 µM. Sekikaic acid is active against the rg recombinant strain of respiratory syncytial virus (RSV; IC50 = 5.69 µg/ml). It inhibits the protein-protein interaction between mixed lineage leukemia 1 (MLL1) and the GACKIX domain of CREB-binding protein (CBP; IC50 = 34 µM).

Chemical Structure

Sekikaic Acid

CAS#607-11-4

Theoretical Analysis

MedKoo Cat#: 464990

Name: Sekikaic Acid

CAS#: 607-11-4

Chemical Formula: C22H26O8

Exact Mass: 418.1628

Molecular Weight: 418.44

Elemental Analysis: C, 63.15; H, 6.26; O, 30.59

Price and Availability

Size	Price	Availability	Quantity
1mg	USD 450.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Sekikaic Acid;

IUPAC/Chemical Name

2-hydroxy-3-((2-hydroxy-4-methoxy-6-propylbenzoyl)oxy)-4-methoxy-6-propylbenzoic acid

InChi Key

CPHXGYQLOSNELY-UHFFFAOYSA-N

InChi Code

InChI=1S/C22H26O8/c1-5-7-12-9-14(28-3)11-15(23)17(12)22(27)30-20-16(29-4)10-13(8-6-2)18(19(20)24)21(25)26/h9-11,23-24H,5-8H2,1-4H3,(H,25,26)

SMILES Code

COC1=CC(CCC)=C(C(O)=C1)C(OC2=C(C=C(C(C(O)=O)=C2O)CCC)OC)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 418.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Dimech J, Feniuk W, Humphrey PP. Antagonist effects of seglitide (MK 678) at somatostatin receptors in guinea-pig isolated right atria. Br J Pharmacol. 1993 Aug;109(4):898-9. doi: 10.1111/j.1476-5381.1993.tb13703.x. PMID: 8104651; PMCID: PMC2175736. 2: Shan L. 177Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg- cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)). 2010 Dec 10 [updated 2011 Jan 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21290631. 3: Shan L. 68Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg- cyclo(Cys-Phe-d-Trp-Lys-Thr-Cys)). 2010 Dec 10 [updated 2011 Jan 18]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21290628. 4: Hannon JP, Nunn C, Stolz B, Bruns C, Weckbecker G, Lewis I, Troxler T, Hurth K, Hoyer D. Drug design at peptide receptors: somatostatin receptor ligands. J Mol Neurosci. 2002 Feb-Apr;18(1-2):15-27. doi: 10.1385/JMN:18:1-2:15. PMID: 11931345. 5: Siehler S, Seuwen K, Hoyer D. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. Eur J Pharmacol. 1998 May 8;348(2-3):311-20. doi: 10.1016/s0014-2999(98)00159-9. PMID: 9652348. 6: Thoss VS, Piwko C, Hoyer D. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization. Naunyn Schmiedebergs Arch Pharmacol. 1996 May;353(6):648-60. doi: 10.1007/BF00167184. PMID: 8738298. 7: Shan L. 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr3]octreotide. 2010 Nov 14 [updated 2010 Dec 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21210566. 8: Shan L. 111In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr3]octreotide. 2010 Nov 14 [updated 2010 Dec 28]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21210567. 9: Reisine T, He HT, Rens-Domiano S, Martin JM, Raynor K, Borislow S, Thermos K. Biochemical properties of somatostatin receptors. Metabolism. 1990 Sep;39(9 Suppl 2):70-3. doi: 10.1016/0026-0495(90)90215-x. PMID: 2169574. 10: Boehm S, Betz H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J Neurosci. 1997 Jun 1;17(11):4066-75. doi: 10.1523/JNEUROSCI.17-11-04066.1997. PMID: 9151723; PMCID: PMC6573526. 11: Li X, Cai L, Xu H, Geng C, Lu J, Tao L, Sun D, Ghishan FK, Wang C. Somatostatin regulates NHE8 protein expression via the ERK1/2 MAPK pathway in DSS-induced colitis mice. Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G954-G963. doi: 10.1152/ajpgi.00239.2016. Epub 2016 Sep 29. PMID: 27686614; PMCID: PMC5130551. 12: Wyatt MA, Jarvie E, Feniuk W, Humphrey PP. Somatostatin sst2 receptor- mediated inhibition of parietal cell function in rat isolated gastric mucosa. Br J Pharmacol. 1996 Nov;119(5):905-10. doi: 10.1111/j.1476-5381.1996.tb15758.x. PMID: 8922739; PMCID: PMC1915956. 13: Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, O'Carroll AM, Patel YC, Schonbrunn A, Taylor JE, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995 Mar;16(3):86-8. doi: 10.1016/s0165-6147(00)88988-9. PMID: 7792934. 14: Schoeffter P, Pérez J, Langenegger D, Schüpbach E, Bobirnac I, Lübbert H, Bruns C, Hoyer D. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur J Pharmacol. 1995 Mar 15;289(1):163-73. doi: 10.1016/0922-4106(95)90180-9. PMID: 7781707. 15: Gao S, Oh YB, Shah A, Park WH, Kim SH. Suppression of ANP secretion by somatostatin through somatostatin receptor type 2. Peptides. 2011 Jun;32(6):1179-86. doi: 10.1016/j.peptides.2011.04.016. Epub 2011 Apr 22. PMID: 21539874. 16: Castro SW, Buell G, Feniuk W, Humphrey PP. Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells. Br J Pharmacol. 1996 Feb;117(4):639-46. doi: 10.1111/j.1476-5381.1996.tb15238.x. PMID: 8646408; PMCID: PMC1909325. 17: Mitchell SN, Sharrott A, Cooper J, Greenslade RG. Ventral subiculum administration of the somatostatin receptor agonist MK-678 increases dopamine levels in the nucleus accumbens. Eur J Pharmacol. 2000 Apr 21;395(1):43-6. doi: 10.1016/s0014-2999(00)00161-8. PMID: 10781672. 18: Yin H, Lee KE, Park SA, Bhattarai JP, Suh BJ, Jeon JG, Kim BG, Park SJ, Han SK. Inhibitory effects of somatostatin on the substantia gelatinosa neurons of trigeminal subnucleus caudalis via somatostatin type 2 receptors in juvenile mice. Brain Res. 2009 Dec 22;1304:49-56. doi: 10.1016/j.brainres.2009.09.070. Epub 2009 Sep 24. PMID: 19782664. 19: Cai L, Li X, Geng C, Lei X, Wang C. Molecular mechanisms of somatostatin- mediated intestinal epithelial barrier function restoration by upregulating claudin-4 in mice with DSS-induced colitis. Am J Physiol Cell Physiol. 2018 Oct 1;315(4):C527-C536. doi: 10.1152/ajpcell.00199.2018. Epub 2018 Jul 18. Erratum in: Am J Physiol Cell Physiol. 2018 Dec 1;315(6):C897. doi: 10.1152/ajpcell.zh0-8366-corr.2018. PMID: 30020824. 20: Feniuk W, Humphrey PP. Somatostatin-induced inhibition of neurotransmission in the mouse isolated vas deferens is resistant to pertussis toxin. Eur J Pharmacol. 1994 Aug 22;261(3):333-7. doi: 10.1016/0014-2999(94)90126-0. PMID: 7813557.

View History

Perfluorobutyric acid